In the article, “Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma”,[1] which appeared in Volume 97, Issue 31 of Medicine, the authors would like to add the funding information “This work was supported by Shandong Medicine and Health Science Technology Development Plan 2014WS0288.” The gene discussed is ERCC1; the disease is esophageal squamous cell carcinoma.